Actavis

Latest Actavis News

1. 
   Parents Blame Alcohol Pads for Toddler's Death

   Mon, 14 Feb 2011

   Industries for its Copaxone product • Novaris Pharmaceuticals for its Extavia (interferon beta 1-b) product • Watson Pharmaceuticals for its Trelstar product • Neuro Resource Group, Inc. for its medical devices and products for injury management
2. Gelnique Approved for Overactive Bladder

   Wed, 28 Jan 2009

   WEDNESDAY, Jan. 28 (HealthDay News) -- The U.S. Food and Drug Administration has approved Watson Pharmaceuticals ' Gelnique (oxybutynin chloride) to treat symptoms of overactive bladder, the company said in a news release
3. Health Highlights: Jan. 1, 2009

   Thu, 1 Jan 2009

   more on sales visits and other promotions. ----- Firm Says FDA Approves Its Generic Version of Nicotine Gum Watson Pharmaceuticals Inc. said Wednesday that the U.S. Food and Drug Administration had approved its generic version of the nicotine
4. Health Highlights: Dec. 31, 2008

   Wed, 31 Dec 2008

   implementation of smoke-free laws," the study said. ----- Firm Says FDA OKs Its Generic Version of Nicotine Gum Watson Pharmaceuticals Inc. said Wednesday that the U.S. Food and Drug Administration had approved its generic version of the nicotine
5. Rapaflo Approved for Enlarged Prostate

   Thu, 9 Oct 2008

   Rapaflo causes the smooth muscles of the prostate to relax, leading to improved urine flow, the manufacturer, Watson Pharmaceuticals , said in a news release. Common side effects include retrograde ejaculation (a condition in which semen enters
6. Health Highlights: Feb. 18, 2008

   Mon, 24 Mar 2008

   the Associated Press reported. The new recall, announced Monday, covers patches sold in the United States by Actavis South Atlantic LLC. That name appears on the outer carton, while the pouches that contain the patches have the company's former